Evidence map›Paper›PMID 8474155›Full record

ArticleJournal of virology1993

Dominant negative mutants of human T-cell leukemia virus type I Rex and human immunodeficiency virus type 1 Rev fail to multimerize in vivo.

H Bogerd, W C Greene

Open access · bronzeAbstract read
In one paragraph

Article in Journal of virology, 1993. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
2.2field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 91 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Implications of the HIV-1 Rev dimer structure at 3.2 A resolution for multimeric binding to the Rev response element.Proceedings of the National Academy of Sciences of the United States of America · 2010
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. The human T-cell leukemia virus Rex protein.Frontiers in bioscience : a journal and virtual library · 2005
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

H BogerdDepartment of Medicine, Howard Hughes Medical Institute, Duke University Medical Center, Durham, North Carolina 27710.
W C Greene
Duke University Hospital · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Human T-cell leukemia virus type I (HTLV-I) Rex and human immunodeficiency virus type 1 (HIV-1) Rev are essential gene products required for the replication of these two pathogenic human retroviruses. Both Rex and Rev act at a posttranscriptional level by binding to highly structured RNA-response elements, the Rex-response element in HTLV-I and the Rev-response element in HIV-1. Using a sensitive in vivo assay of protein-protein interaction, we now demonstrate that the HTLV-I Rex and HIV-1 Rev proteins readily form homomultimeric complexes in the absence of their cognate RNA-response elements yet fail to form heteromultimeric complexes with each other. Dominant negative mutations have been identified in both the rex and rev genes which presumably specify a critical activation or effector domain in each of these viral transactivators. Surprisingly, these dominant negative mutants of Rex and Rev fail to interact in vivo. These findings raise the possibility that the binding of nonfunctional monomers rather than functional multimers underlies the transdominant phenotype of these Rex and Rev mutants. Further, it seems likely that the assembly of functional and stable multimers of Rex and Rev in vivo may depend not only on the intrinsic multimerization domains of these proteins but also on the binding of a bridging cellular cofactor to the related activation domains present in each viral transactivator.

Indexed as

Saccharomyces cerevisiae ProteinsTranscription FactorsAcquired Immunodeficiency SyndromeAmino Acid SequenceChloramphenicol O-AcetyltransferaseDNA-Binding ProteinsFungal ProteinsGene Products, revGene Products, rexHerpes Simplex Virus Protein Vmw65HIV-1Human T-lymphotropic virus 1Macromolecular SubstancesMolecular Sequence DataMutationRecombinant Fusion ProteinsChloramphenicol O-AcetyltransferaseDNA-Binding ProteinsFungal ProteinsGAL4 protein, S cerevisiaeGene Products, revGene Products, rexHerpes Simplex Virus Protein Vmw65Macromolecular SubstancesRecombinant Fusion Proteinsrev Gene Products, Human Immunodeficiency VirusSaccharomyces cerevisiae ProteinsTranscription Factors

Identifiers

PMID8474155
PMCPMC237568
OpenAlexW1550221459

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.